You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urothelial cancer

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Radiotherapy Side Effect Trial in Denmark (Proton therapy, Photon therapy)

Recruiting
  • Prostate Cancer
  • Radiotherapy Side Effect
  • Proton therapy
  • Photon therapy
  • Aarhus, Central Region, Denmark
  • +6 more
Apr 21, 2022

Refractory Metastatic Colorectal Cancer Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 16, 2022

Advanced Malignant Tumor Trial in Seattle (Communication Intervention, Questionnaire Administration)

Terminated
  • Advanced Malignant Neoplasm
  • Communication Intervention
  • Questionnaire Administration
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 10, 2021

Alzheimer, Late Onset, Stroke, Heart Failure Trial in Yilan (Health Education Manual, manual)

Completed
  • Alzheimer Disease, Late Onset
  • +7 more
  • Health Education Manual
  • manual
  • Yilan, Taiwan
    Wen-Shiou Pan
Jun 6, 2022

Lung Cancer, Lung Non-Small Cell Carcinoma, Lung; Node Trial in Bologna (Tornado (Cook))

Recruiting
  • Lung Cancer
  • +2 more
  • Tornado (Cook)
  • Bologna, Emilia Romagna, Italy
    Gian Piero Bandelli
Apr 5, 2023

Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging

Completed
Has Results
  • Stage II Prostate Adenocarcinoma
  • Stage III Prostate Adenocarcinoma
  • Palo Alto, California
    Stanford University, School of Medicine
Mar 2, 2022

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Batumi, Tbilisi (Tenalisib)

Active, not recruiting
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Batumi, Georgia
  • +2 more
May 2, 2022

Resectable Pancreatic Cancer Trial in Denmark (ctDNA)

Recruiting
  • Resectable Pancreatic Cancer
  • ctDNA
  • Aalborg, Denmark
  • +4 more
Mar 27, 2023

SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

Not yet recruiting
  • SCLC,Extensive Stage
  • AK104 IV infusion；Chiauranib oral
  • Changchun, Jilin, China
    Jilin Province Cancer Hospital
Aug 16, 2022

Epithelial Ovarian Cancer Trial in Shanghai (LCAR-M23 cells)

Terminated
  • Epithelial Ovarian Cancer
  • LCAR-M23 cells
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Aug 15, 2022

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome Trial in Roma (Molecular characterization of solid tumor in

Recruiting
  • RASopathy
  • +3 more
  • Molecular characterization of solid tumor in RASopathies
  • Roma, Italy
    Department of Woman and Child Health and Public Health, Fondazio
Feb 27, 2023

Breast Cancer, Physical Activity Trial in Galveston, Houston (Active video game teleconference support group, Standard support

Active, not recruiting
  • Breast Cancer
  • Physical Activity
  • Active video game teleconference support group
  • Standard support group + pedometer
  • Galveston, Texas
  • +1 more
Oct 26, 2021

Prevention of Venous Thromboembolism Trial in Italy (Rivaroxaban, Placebo)

Completed
  • Prevention of Venous Thromboembolism
  • Pozzuoli, Napoli, Italy
  • +16 more
Mar 10, 2022

ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)

Not yet recruiting
  • ER+ Breast Cancer
  • +2 more
  • White Wine
  • Grape Juice
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 1, 2022

Lymph Node Cancer Metastatic Trial in Hospitalet de Llobregat (Axillary mapping reverse)

Recruiting
  • Lymph Node Cancer Metastatic
  • Axillary mapping reverse
  • Hospitalet de Llobregat, Barcelona, Spain
    Hospital de Bellvitge
Aug 2, 2022

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting
  • Endometrial Cancer
  • Anchorage, Alaska
  • +78 more
Jul 25, 2022

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Cancer, Cognitive Late Effects Trial in Philadelphia (Atomoxetine)

Withdrawn
  • Cancer
  • Cognitive Late Effects
  • Philadelphia, Pennsylvania
    Temple University
Mar 30, 2022

Non-small Cell Lung Cancer EGFR Exon 20 Insertion

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
    • Cordoba, Andalucia, Spain
    • +14 more
    Nov 1, 2022

    Colorectal Tumors, Tumor Metastasis, Liver Tumors Trial in Shanghai (chemo ± targeted therapy)

    Completed
    • Colorectal Neoplasms
    • +3 more
    • chemotherapy ± targeted therapy
    • Shanghai, Shanghai, China
      Zhongshan hospital, Fudan university
    Jun 12, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Duarte, California
    • +2 more
    Oct 7, 2022

    Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)

    Recruiting
    • Locally Advanced Pancreatic Cancer
    • Washington, District of Columbia
    • +1 more
    Oct 10, 2022

    Ovarian Cancer Trial in New York (90Y-hu3S193, 111In-hu3S193)

    Completed
    Has Results
    • Ovarian Cancer
    • 90Y-hu3S193
    • 111In-hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022